Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Key Takeaways:

• Pfizer welcomes both investors and the public to this webcast.
• Albert Bourla, Pfizer’s Chairman and CEO, will lead the discussion.
• The event takes place on Monday, June 8, 2026, at 8:00 a.m. EDT.
• Registration details are available on Pfizer’s investor website.
• This forum is part of the Goldman Sachs 47th Annual Global Healthcare Conference.

Pfizer’s Open Invitation

Pfizer Inc. (NYSE: PFE) has announced that investors and members of the general public are invited to join a webcast of a high-profile discussion. “Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla,” reads the company’s statement. Bourla currently serves as Pfizer’s Chairman and Chief Executive Officer, bringing firsthand insight into the pharmaceutical giant’s strategies and research focus.

The Conference Platform

Scheduled as part of the Goldman Sachs 47th Annual Global Healthcare Conference, the webcast will showcase talks on industry trends and future directions in healthcare. The conference is set to convene thought leaders, experts, and influential stakeholders across the healthcare continuum, offering a reflection of broader global health concerns and innovations.

When and How to Tune In

Listeners can join the webcast on Monday, June 8, 2026, at 8:00 a.m. EDT, an early start that underlines the international significance of the event. According to Pfizer, “To listen to the webcast, visit our web site at www.pfizer.com/investors.” The company confirms that full details and registration instructions are readily accessible at the same site. “Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today,” the announcement adds.

A Look Ahead

While Pfizer has not released a specific agenda for the webcast beyond a discussion with Albert Bourla, interested parties can anticipate timely commentary on healthcare developments, reflective of the current industry landscape. As an open invitation and part of a prominent conference, it signals Pfizer’s commitment to engaging with both its shareholders and the broader public on matters of research, business strategies, and future partnerships.